Juan Pablo
de Torres Tajes
Consultor Médico
Instituto de Investigación Sanitaria de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (9)
2024
-
Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience
Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15
-
Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP
Archivos de Bronconeumologia, Vol. 60, Núm. 9, pp. 559-564
-
Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience
Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100
-
Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma
eBioMedicine, Vol. 102
2022
-
Emphysema: the risk of cancer and the impact on cancer care
ERS Monograph, Vol. 2022, Núm. 98, pp. 105-117
2021
-
Endobronchial autologous bone marrow-mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial
ERJ Open Research, Vol. 7, Núm. 2, pp. 00773-2020
-
Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort
Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 36-41
-
Surgical Outcomes in a Lung Cancer-Screening Program Using Low Dose Computed Tomography
Archivos de Bronconeumologia, Vol. 57, Núm. 2, pp. 101-106
2019
-
The effect of radiographic emphysema in assessing lung cancer risk
Thorax, Vol. 74, Núm. 9, pp. 858-864